Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO , Oct. 11, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on October 10, 2022 , the Compensation Committee of its Board of Directors granted inducement equity grants to seven new employees, consisting of inducement restricted stock units, or RSUs,